glp-1 drugs india pharma companies develop versions of Wegovy to get in on weight-loss windfall India's GLP-1 Boom: Tread with

- Ngm ru: Maca sau khi phi kh c th ngm cng ru, gip bi b sinh kh nam gii

Mahaman, Y

severe or persistent upper abdominal pain should prompt urgent medical assessment [10] [11] Dehydration and acute kidney injury (AKI): gastrointestinal fluid losses can lead to dehydration, which may precipitate AKI, particularly in those with pre-existing renal impairment or those taking nephrotoxic medicines Delayed gastric emptying: this may affect the absorption of orally administered medicines, including contraceptive pills and thyroid replacement therapy [11] Injection site reactions: redness, bruising, or discomfort at the subcutaneous injection site Heart rate changes: increases in resting heart rate have been noted with GLP-1 class agents [14] [15] Hypoglycaemia: particularly if used alongside insulin or sulphonylureas Potential pancreatitis risk: a class concern with GLP-1 receptor agonists

Same peptide, different routes

The HPA co-activation mechanism runs through CRH